Dimensional Fund Advisors LP Century Therapeutics, Inc. Transaction History
Dimensional Fund Advisors LP
- $376 Billion
- Q2 2024
A detailed history of Dimensional Fund Advisors LP transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 75,315 shares of IPSC stock, worth $113,725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75,315
Previous 31,160
141.7%
Holding current value
$113,725
Previous $130,000
47.69%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IPSC
# of Institutions
62Shares Held
35MCall Options Held
7KPut Options Held
300-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$8.17 Million2.82% of portfolio
-
Vr Adviser, LLC New York, NY5.39MShares$8.14 Million1.51% of portfolio
-
Boxer Capital, LLC San Diego, CA4.9MShares$7.4 Million0.69% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$4.84 Million0.71% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$4.37 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $88.9M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...